Sattva Sukun Lifecare holds EOGM on July 19, approves key director appointments and acquisition

NOOR MOHMMED

    19/Jul/2025

  • Sattva Sukun Lifecare held its EOGM on July 19, 2025, via video conferencing with 45 members in attendance.

  • Shareholders approved appointment of directors and acquisition of 51% in Pavapuri Export Pvt Ltd via e-voting.

  • E-voting results and Scrutinizer’s Report will be announced within 2 working days on the company’s website.

On Saturday, 19th July 2025, Sattva Sukun Lifecare Limited (formerly known as Mayukh Dealtrade Limited) successfully conducted its Extra Ordinary General Meeting (EOGM) via Video Conferencing (VC)/Other Audio Visual Means (OAVM) in compliance with the Companies Act, 2013, and applicable MCA circulars and SEBI regulations.

The EOGM, which started at 02:00 PM and concluded at 02:16 PM, saw the participation of 45 shareholders. This marked a crucial governance milestone for the company as shareholders deliberated and approved three major resolutions including two director appointments and a strategic equity acquisition.

EOGM Conducted in Full Compliance with SEBI and MCA Guidelines

The meeting was conducted in accordance with:

  • Regulation 30 of SEBI (LODR) Regulations, 2015

  • Section 108 of the Companies Act, 2013

  • Various circulars issued by the Ministry of Corporate Affairs, including General Circular Nos. 14/2020, 17/2020, 20/2020, and 05/2022

The e-voting platform provided by NSDL was made available to eligible shareholders from 16th July, 2025 (9:00 AM) to 18th July, 2025 (5:00 PM). Members who attended the meeting through VC/OAVM were also given the facility to cast their vote during the meeting on the same platform.

The cut-off date for determining eligibility for voting was 12th July 2025, and voting remained open for 30 minutes post-meeting.

Key Participants at the EOGM

Directors Present:

  • Mr. Mit Tarunkumar Brahmbhatt – Managing Director

  • Mr. Tanmay Paresh Shah – Independent Director

Key Managerial Personnel (KMPs):

  • Mr. Atish Ananta Kamble – Chief Financial Officer

  • Mrs. Poonam Rani – Company Secretary

By Invitation:

  • Mr. Brajesh Gupta, Practicing Company Secretary (Scrutinizer)

Mr. Mit Tarunkumar Brahmbhatt was unanimously elected to chair the meeting. The resolutions were read out by Mrs. Poonam Rani, Company Secretary, and members who had registered as speakers were invited to ask questions, which were addressed during the meeting.

Key Resolutions Passed by Shareholders

1. Appointment of Mr. Tanmay Paresh Shah as Non-Executive Independent Director

  • Nature: Special Resolution

  • Mode of Voting: E-voting

  • Mr. Shah, holding DIN: 11046372, was regularized as an independent director.

2. Appointment of Mr. Gaurav Surendra Nair as Non-Executive Non-Independent Director

  • Nature: Ordinary Resolution

  • Mode of Voting: E-voting

  • Mr. Nair, holding DIN: 11077203, was confirmed as a director on the board.

3. Acquisition of 51% and above equity in M/S Pavapuri Export Private Limited

  • Nature: Special Resolution

  • Mode of Voting: E-voting

  • This move indicates a strategic investment decision for expansion or diversification.

The resolution regarding the acquisition was added via a corrigendum to the original notice of the EOGM and appropriately read out to the shareholders during the meeting.

Voting and Result Declaration

The Scrutinizer, M/s Brajesh Gupta & Co., confirmed the presence of quorum and validated the entire e-voting process. The company has assured that:

  • Results of the voting, along with the Scrutinizer’s Report, will be published within two working days

  • Results will be displayed on the official company website www.mayukh.co.in

  • They will also be intimated to BSE Limited, where the company is listed under Scrip Code: 539519

This transparency and commitment to disclosure are key pillars in Sattva Sukun Lifecare’s investor relations strategy.

Strategic Relevance of the EOGM

The acquisition of Pavapuri Export Pvt Ltd, if executed, could mark a significant turning point in the company’s diversification or growth path. Acquiring a controlling stake (51% or more) suggests the company is aiming to:

  • Expand into new verticals

  • Strengthen its supply chain or distribution

  • Enter a complementary or fast-growing market segment

The regularization of independent and non-independent directors further reflects the company’s ongoing effort to strengthen governance, bring in new expertise, and align with long-term strategic goals.

About Sattva Sukun Lifecare Limited

Formerly known as Mayukh Dealtrade Limited, the company has undergone a transformation and rebranding to Sattva Sukun Lifecare Limited. This change signals a shift in focus, possibly towards the healthcare, wellness, or lifecare sector, as indicated by the new name.

The company continues to maintain its:

  • Corporate Office: Office No.101, 1st Floor, Crystal Rose CHS Ltd., Mahavir Nagar, Kandivali West, Mumbai - 400067

  • Tel: +91-22-2868 4491

  • Email: info@mayukh.co.in

  • Website: www.mayukh.co.in

  • CIN: L51219MH1980PLC329224

What to Expect Next?

The announcement of the voting results and a detailed Scrutinizer’s Report within two working days will finalize the decisions taken. The acquisition resolution, in particular, is expected to generate investor interest and market reaction once financial details or deal structures are disclosed in future communications.


The Upcoming IPOs in this week and coming weeks are Shanti Gold InternationalIndiqube SpacesGNG ElectronicsBrigade Hotel VenturesTSC IndiaPatel Chem SpecialitiesMonarch Surveyors & Engineering ConsultantsTSC IndiaSwastika CastalSavy InfraNSDL.


The Closed IPOs are Monika AlcobevAnthem Biosciences, Spunweb Nonwoven.


Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.


Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Related News
onlyfans leakedonlyfan leaksonlyfans leaked videos